Codexis (NASDAQ: CDXS) insider transactions
In the twelve months to 10 November 2026, executives and directors of Codexis reported 22 open-market sales of 2,192,430 shares ($4.0m) and 0 open-market purchases, by 6 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 9 November 2026 | De Vre Raymond | Director | Open-market sale | −1,088 | $1.11 | 83,723 | Form 4 |
| 12 October 2026 | Moore Alison | President and CEO | Open-market sale | −6,335 | $1.36 | 244,171 | Form 4 |
| 12 October 2026 | Erbez Georgia | See Remarks | Open-market sale | −6,335 | $1.36 | 60,475 | Form 4 |
| 11 June 2026 | De Vre Raymond | Director | Open-market sale | −2,605 | $2.37 | 84,811 | Form 4 |
| 24 February 2026 | Lutz Stefan | Chief Scientific Officer | Open-market sale | −5,862 | $1.13 | 130,421 | Form 4 |
| 6 February 2026 | Moore Alison | President and CEO | Open-market sale | −3,826 | $1.31 | 250,506 | Form 4 |
| 6 February 2026 | Erbez Georgia | See Remarks | Open-market sale | −3,826 | $1.31 | 66,810 | Form 4 |
| 6 February 2026 | Lutz Stefan | Chief Scientific Officer | Open-market sale | −2,492 | $1.31 | 136,283 | Form 4 |
| 7 January 2026 | Lutz Stefan | Cso | Open-market sale | −4,685 | $1.70 | 138,775 | Form 4 |
| 1 December 2025 | Opaleye Management Inc. | — | Open-market sale | −245,000 | $1.67 | 9,955,000 | Form 4 |
| 1 December 2025 | Opaleye Management Inc. | — | Open-market sale | −8,533 | $1.67 | 179,989 | Form 4 |
| 28 November 2025 | Opaleye Management Inc. | — | Open-market sale | −105,000 | $1.75 | 10,200,000 | Form 4 |
| 28 November 2025 | Opaleye Management Inc. | — | Open-market sale | −2,490 | $1.75 | 188,522 | Form 4 |
| 26 November 2025 | Opaleye Management Inc. | — | Open-market sale | +148,318 | $1.74 | 10,305,000 | Form 4 |
| 26 November 2025 | Opaleye Management Inc. | — | Open-market sale | −5,000 | $1.74 | 191,012 | Form 4 |
| 21 November 2025 | Wolf Dennis P | Director | Open-market sale | −8,952 | $1.56 | 138,951 | Form 4 |
| 13 November 2025 | Moore Alison | President and CEO | Grant or award | +85,000 | — | 254,332 | Form 4 |
| 12 November 2025 | Opaleye Management Inc. | — | Open-market sale | +890,000 | $1.94 | 10,618,318 | Form 4 |
| 12 November 2025 | Opaleye Management Inc. | — | Open-market sale | −27,459 | $1.94 | 196,012 | Form 4 |
| 12 November 2025 | Opaleye Management Inc. | — | Open-market sale | −165,000 | $1.96 | 10,453,318 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Codexis page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.